2014 BRFSS Asthma Call-Back Survey Prevalence Tables
TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2014
State/Territory | Current | Active | ||||||
---|---|---|---|---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
Alabama | 213 | 40.2 | 8.7 | (23.1 – 57.3) | 228 | 39.5 | 8.3 | (23.2 – 55.8) |
Florida | 214 | 33.1 | 5.4 | (22.5 – 43.7) | 229 | 32.7 | 5.3 | (22.3 – 43.1) |
Kansas | 264 | 37.2 | 6.2 | (25.0 – 49.4) | 278 | 36.8 | 6.1 | (24.8 – 48.8) |
Louisiana | 93 | 37.2 | 10.3 | (17.0 – 57.4) | 106 | 31.1 | 9.0 | (13.5 – 48.7) |
Massachusetts | 139 | 42.5 | 7.7 | (27.4 – 57.6) | 141 | 41.5 | 7.5 | (26.8 – 56.2) |
5 state total | 923 | 36.9 | 3.5 | (30.0 – 43.8) | 982 | 35.8 | 3.4 | (29.1 – 42.5) |
Median | 37.2 | 36.8 | ||||||
Range | 33.1-42.5 | 31.1-41.5 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30